Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

Impact · against what's priced in

Simulations Plus faces severe fundamental and governance risks following a significant revenue guidance cut and disclosures regarding accounting disputes with its former auditor. Beta Bionics is likewise under investigation for potential securities law violations, creating new legal overhang for both companies.

SLP−0.90: No priced-in read yet

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

What matters in this story

ROSEN, A TOP-RANKED LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

What matters in this story

ROSEN, A TOP-RANKED LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

How each ticker is affected

Track these names every morning.

Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (MDGL) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Pharmaceuticals ETF (IHE) Hits a New 52-Week High

Kaplan Fox Notifies Investors of Coastal Financial Corporation (NASDAQ: CCB) of a Securities Fraud Class Action Deadline on December 1, 2026

Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

What matters in this story

Next reads from the same story arc

ROSEN, A TOP-RANKED LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

What matters in this story

Next reads from the same story arc

ROSEN, A TOP-RANKED LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

How each ticker is affected

Track these names every morning.

Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (MDGL) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Pharmaceuticals ETF (IHE) Hits a New 52-Week High

Kaplan Fox Notifies Investors of Coastal Financial Corporation (NASDAQ: CCB) of a Securities Fraud Class Action Deadline on December 1, 2026

Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs